NASDAQ:DRAD - Digirad Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$1.65 -0.03 (-1.79 %)
(As of 06/20/2018 07:35 AM ET)
Previous Close$1.6750
Today's Range$1.65 - $1.70
52-Week Range$1.25 - $4.45
Volume30,700 shs
Average Volume40,208 shs
Market Capitalization$33.70 million
P/E RatioN/A
Dividend Yield13.13%
Digirad logoDigirad Corporation provides healthcare solutions in the United States. It operates through Diagnostic Services, Mobile Healthcare, and Diagnostic Imaging segments. The Diagnostic Services segment provides nuclear and ultrasound imaging services to physicians who perform nuclear imaging, echocardiography, vascular or general ultrasound tests, imaging systems, radiopharmaceuticals, and licensing services, as well as offers remote cardiac event monitoring services. The Mobile Healthcare segment offers contract diagnostic imaging services, including computerized tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), PET/CT, and nuclear medicine and healthcare services to hospitals, integrated delivery networks, and federal institutions on a long-term contract basis, as well as provisional services to institutions that are in transition. The Diagnostic Imaging segment develops and sells gamma camera imaging systems, such as nuclear cardiac imaging systems and general purpose nuclear imaging systems to physician offices and hospitals; and offers camera maintenance services. Digirad Corporation was founded in 1985 and is headquartered in Suwanee, Georgia.

Receive DRAD News and Ratings via Email

Sign-up to receive the latest news and ratings for DRAD and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Electromedical equipment


Debt-to-Equity Ratio0.42
Current Ratio1.62
Quick Ratio1.20


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$118.34 million
Price / Sales0.28
Cash Flow$0.6933 per share
Price / Cash2.38
Book Value$1.39 per share
Price / Book1.19


EPS (Most Recent Fiscal Year)N/A
Net Income$-35,730,000.00
Net Margins-25.76%
Return on Equity-2.36%
Return on Assets-1.28%


Outstanding Shares20,120,000

Digirad (NASDAQ:DRAD) Frequently Asked Questions

What is Digirad's stock symbol?

Digirad trades on the NASDAQ under the ticker symbol "DRAD."

How often does Digirad pay dividends? What is the dividend yield for Digirad?

Digirad declared a quarterly dividend on Wednesday, May 2nd. Shareholders of record on Tuesday, May 15th will be given a dividend of $0.055 per share on Wednesday, May 30th. This represents a $0.22 annualized dividend and a yield of 13.33%. The ex-dividend date of this dividend is Monday, May 14th. View Digirad's Dividend History.

How were Digirad's earnings last quarter?

Digirad Co. (NASDAQ:DRAD) issued its quarterly earnings data on Tuesday, May, 1st. The medical equipment provider reported ($0.07) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.01) by $0.06. The medical equipment provider had revenue of $25.47 million for the quarter. Digirad had a negative return on equity of 2.36% and a negative net margin of 25.76%. View Digirad's Earnings History.

When is Digirad's next earnings date?

Digirad is scheduled to release their next quarterly earnings announcement on Friday, August, 3rd 2018. View Earnings Estimates for Digirad.

What price target have analysts set for DRAD?

1 Wall Street analysts have issued twelve-month price objectives for Digirad's shares. Their forecasts range from $6.00 to $6.00. On average, they expect Digirad's stock price to reach $6.00 in the next year. View Analyst Ratings for Digirad.

Who are some of Digirad's key competitors?

Who are Digirad's key executives?

Digirad's management team includes the folowing people:
  • Mr. Matthew Gabel Molchan, Principal Financial Officer, Pres, CEO & Director (Age 51)
  • Mr. Martin B. Shirley, Pres of Digirad Imaging Solutions (Age 56)
  • Mr. Virgil J. Lott, Pres of Diagnostic Imaging (Age 60)
  • Mr. James M. Portwood, VP of Operations
  • Mr. Bob Halbert, Sr. Director of Human Resource

Has Digirad been receiving favorable news coverage?

Headlines about DRAD stock have been trending somewhat positive this week, Accern reports. Accern rates the sentiment of news coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Digirad earned a coverage optimism score of 0.16 on Accern's scale. They also gave news headlines about the medical equipment provider an impact score of 46.66 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the near future.

Who are Digirad's major shareholders?

Digirad's stock is owned by many different of retail and institutional investors. Top institutional investors include CANNELL CAPITAL LLC (10.76%), Cannell Capital LLC (10.74%), CANNELL CAPITAL LLC (10.76%), Punch & Associates Investment Management Inc. (4.11%), Ancora Advisors LLC (2.86%) and New York State Common Retirement Fund (2.79%). Company insiders that own Digirad stock include Cannell Capital Llc, Jeffrey E Eberwein, Jeffry R Keyes, Matthew G Molchan, Michael A Cunnion and Virgil Lott. View Institutional Ownership Trends for Digirad.

Which institutional investors are selling Digirad stock?

DRAD stock was sold by a variety of institutional investors in the last quarter, including ARS Investment Partners LLC and Punch & Associates Investment Management Inc.. Company insiders that have sold Digirad company stock in the last year include Cannell Capital Llc, Michael A Cunnion and Virgil Lott. View Insider Buying and Selling for Digirad.

Which institutional investors are buying Digirad stock?

DRAD stock was bought by a variety of institutional investors in the last quarter, including Ancora Advisors LLC, New York State Common Retirement Fund, Cannell Capital LLC and Shepherd Kaplan Krochuk LLC. Company insiders that have bought Digirad stock in the last two years include Cannell Capital Llc, Jeffrey E Eberwein, Jeffry R Keyes and Matthew G Molchan. View Insider Buying and Selling for Digirad.

How do I buy shares of Digirad?

Shares of DRAD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Digirad's stock price today?

One share of DRAD stock can currently be purchased for approximately $1.65.

How big of a company is Digirad?

Digirad has a market capitalization of $33.70 million and generates $118.34 million in revenue each year. Digirad employs 515 workers across the globe.

How can I contact Digirad?

Digirad's mailing address is 1048 INDUSTRIAL COURT, SUWANEE GA, 30024. The medical equipment provider can be reached via phone at 858-726-1600 or via email at [email protected]

MarketBeat Community Rating for Digirad (DRAD)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  219 (Vote Outperform)
Underperform Votes:  155 (Vote Underperform)
Total Votes:  374
MarketBeat's community ratings are surveys of what our community members think about Digirad and other stocks. Vote "Outperform" if you believe DRAD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DRAD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/20/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.